Nasdaq
$27.97▲ 2.83%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $98.2MShares out 3.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 9.4After-hours26.09.05 05:06SCHEDULE 13G/AOwnership#●●●
RF Acquisition Corp II
Karpus Management, Inc. has filed a Schedule 13G/A to report changes in its beneficial ownership of RF Acquisition Corp II. This filing serves as a routine update regarding the investor's equity position in the company.…more
$27.97+2.83%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.20After-hours26.08.21 05:50425Other
RF Acquisition Corp II
RF Acquisition Corp II held an extraordinary general meeting on August 19, 2026, where shareholders approved the business combination and merger with Nanyang Biologics Pte. Ltd. with 6,765,584 votes in favor. A total of 3,956,323 ordinary shares were submitted for redemption, and the final completion of the transaction remains subject to closing conditions.…more
$27.97+2.83%vs prev closeView filingShare - 8.20After-hours26.08.21 05:498-KKey event
RF Acquisition Corp II
RF Acquisition Corp II held an extraordinary general meeting on August 19, 2026, and approved the business combination and merger with Nanyang Biologics Pte. Ltd. All proposals, including the business combination, merger, and equity incentive plan, were passed with 6,765,584 votes in favor. Additionally, shareholders submitted preliminary requests to redeem 3,956,323 ordinary shares for cash.…more
$27.97+2.83%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.21Overnight26.08.21 13:34Bullish#●●●#●●●#●●●
Werewolf Therapeutics Surges 90% After Selling Tech Platforms
Werewolf Therapeutics jumped after announcing the sale of its pre-clinical technology platforms to EMD Serono for $33 million. This deal provides the company with non-dilutive cash while allowing it to retain its clinical-stage programs.…more
$27.97+2.83%vs prev closeShareBenzinga
- 8.21Overnight26.08.21 12:32
●●●●●●●● ●●●●● ●●●●●●
Shares of RF Acquisition Corp soared after shareholders approved the business combination with Singapore-based Nanyang Biologics. Investors should remain cautious as the final redemption figures for shares remain subject to change before the deal closes.…more
$27.97+2.83%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report